Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 32 | 2024 | 4371 | 4.310 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 19 | 2024 | 3701 | 2.180 |
Why?
|
Conduct Disorder | 6 | 2023 | 245 | 1.360 |
Why?
|
Opioid-Related Disorders | 7 | 2024 | 2138 | 1.220 |
Why?
|
Central Nervous System Stimulants | 10 | 2023 | 1174 | 1.080 |
Why?
|
Parents | 5 | 2021 | 3549 | 0.660 |
Why?
|
Comorbidity | 10 | 2023 | 10551 | 0.650 |
Why?
|
Psychoses, Substance-Induced | 1 | 2019 | 99 | 0.640 |
Why?
|
Physician Impairment | 1 | 2019 | 72 | 0.620 |
Why?
|
Behavior, Addictive | 1 | 2023 | 462 | 0.590 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2021 | 936 | 0.570 |
Why?
|
Mental Disorders | 4 | 2021 | 6796 | 0.540 |
Why?
|
Schools | 2 | 2017 | 1480 | 0.530 |
Why?
|
Adolescent | 35 | 2024 | 87810 | 0.510 |
Why?
|
Physicians, Women | 1 | 2021 | 495 | 0.490 |
Why?
|
Autistic Disorder | 2 | 2021 | 1216 | 0.490 |
Why?
|
Harm Reduction | 4 | 2024 | 145 | 0.490 |
Why?
|
Siblings | 2 | 2016 | 824 | 0.490 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.480 |
Why?
|
Methylphenidate | 4 | 2019 | 488 | 0.470 |
Why?
|
Child of Impaired Parents | 1 | 2018 | 459 | 0.470 |
Why?
|
Psychometrics | 2 | 2021 | 3051 | 0.460 |
Why?
|
Checklist | 1 | 2020 | 827 | 0.440 |
Why?
|
Physicians | 2 | 2023 | 4591 | 0.420 |
Why?
|
Social Support | 2 | 2024 | 2145 | 0.400 |
Why?
|
Young Adult | 25 | 2024 | 58741 | 0.400 |
Why?
|
Substance Abuse, Intravenous | 3 | 2022 | 530 | 0.380 |
Why?
|
Students | 4 | 2020 | 1730 | 0.360 |
Why?
|
Alcoholism | 2 | 2019 | 1961 | 0.360 |
Why?
|
Psychiatry | 1 | 2022 | 1689 | 0.350 |
Why?
|
Family | 2 | 2019 | 3189 | 0.340 |
Why?
|
Psychopathology | 2 | 2024 | 429 | 0.340 |
Why?
|
Communication | 2 | 2023 | 3849 | 0.330 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3865 | 0.320 |
Why?
|
Delivery of Health Care | 2 | 2024 | 5325 | 0.320 |
Why?
|
Euphoria | 2 | 2018 | 65 | 0.300 |
Why?
|
Bipolar Disorder | 6 | 2023 | 5078 | 0.300 |
Why?
|
Child | 17 | 2023 | 79806 | 0.280 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8552 | 0.280 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3763 | 0.270 |
Why?
|
Humans | 55 | 2024 | 760621 | 0.270 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 4744 | 0.260 |
Why?
|
Naltrexone | 2 | 2018 | 317 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3164 | 0.250 |
Why?
|
Adult | 23 | 2024 | 219994 | 0.250 |
Why?
|
Qualitative Research | 2 | 2024 | 2963 | 0.220 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14495 | 0.220 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.210 |
Why?
|
Residential Treatment | 1 | 2024 | 107 | 0.210 |
Why?
|
Personal Autonomy | 1 | 2024 | 302 | 0.200 |
Why?
|
Interview, Psychological | 2 | 2016 | 810 | 0.190 |
Why?
|
Antisocial Personality Disorder | 2 | 2023 | 224 | 0.190 |
Why?
|
Depression | 1 | 2021 | 8044 | 0.190 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.180 |
Why?
|
Nursing Staff, Hospital | 1 | 2024 | 344 | 0.180 |
Why?
|
Massachusetts | 6 | 2024 | 8803 | 0.180 |
Why?
|
Child Care | 1 | 2021 | 121 | 0.180 |
Why?
|
Female | 27 | 2024 | 391270 | 0.170 |
Why?
|
Tetrahydrofolates | 1 | 2019 | 58 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2020 | 22053 | 0.150 |
Why?
|
Focus Groups | 1 | 2024 | 1378 | 0.150 |
Why?
|
Marijuana Abuse | 1 | 2022 | 411 | 0.150 |
Why?
|
Efficiency | 1 | 2021 | 477 | 0.150 |
Why?
|
Male | 22 | 2024 | 359744 | 0.150 |
Why?
|
Behavior Therapy | 1 | 2022 | 868 | 0.140 |
Why?
|
Interviews as Topic | 1 | 2024 | 2659 | 0.140 |
Why?
|
Mass Screening | 3 | 2021 | 5423 | 0.130 |
Why?
|
Risk Factors | 8 | 2022 | 74359 | 0.130 |
Why?
|
Narcotic Antagonists | 2 | 2018 | 583 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2024 | 768 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 436 | 0.130 |
Why?
|
Consensus Development Conferences as Topic | 3 | 2021 | 169 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 496 | 0.130 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25942 | 0.130 |
Why?
|
Social Environment | 1 | 2020 | 1022 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2017 | 1387 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17790 | 0.120 |
Why?
|
Prescriptions | 1 | 2017 | 388 | 0.120 |
Why?
|
Child Psychiatry | 1 | 2017 | 226 | 0.120 |
Why?
|
United States | 5 | 2023 | 72461 | 0.110 |
Why?
|
Psychotherapy | 1 | 2022 | 1640 | 0.110 |
Why?
|
ROC Curve | 1 | 2020 | 3568 | 0.110 |
Why?
|
Postpartum Period | 1 | 2019 | 1167 | 0.100 |
Why?
|
Mood Disorders | 1 | 2019 | 1124 | 0.100 |
Why?
|
Program Evaluation | 1 | 2021 | 2493 | 0.100 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3696 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 510 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3448 | 0.090 |
Why?
|
Delayed-Action Preparations | 3 | 2019 | 961 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3113 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1378 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39261 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2023 | 80372 | 0.080 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2714 | 0.080 |
Why?
|
Patient Care Team | 1 | 2021 | 2511 | 0.080 |
Why?
|
Mothers | 1 | 2020 | 2186 | 0.080 |
Why?
|
Family Health | 1 | 2014 | 1257 | 0.080 |
Why?
|
Substance Abuse Detection | 1 | 2012 | 301 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3213 | 0.080 |
Why?
|
Prevalence | 4 | 2019 | 15687 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3061 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2019 | 3392 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5397 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4538 | 0.060 |
Why?
|
Sex Factors | 2 | 2016 | 10547 | 0.060 |
Why?
|
Pediatrics | 1 | 2020 | 3586 | 0.060 |
Why?
|
Adolescent Behavior | 1 | 2014 | 1175 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15289 | 0.060 |
Why?
|
Double-Blind Method | 4 | 2019 | 12427 | 0.060 |
Why?
|
Universities | 2 | 2020 | 992 | 0.050 |
Why?
|
Menopause | 1 | 2011 | 1640 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7806 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20080 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12531 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13314 | 0.050 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2021 | 21 | 0.050 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2023 | 306 | 0.050 |
Why?
|
Institutionalization | 1 | 2021 | 105 | 0.040 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2021 | 303 | 0.040 |
Why?
|
Episode of Care | 1 | 2021 | 127 | 0.040 |
Why?
|
Confidentiality | 1 | 2024 | 609 | 0.040 |
Why?
|
Anger | 1 | 2022 | 401 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 379 | 0.040 |
Why?
|
Middle Aged | 3 | 2024 | 220352 | 0.040 |
Why?
|
Self Report | 2 | 2022 | 3711 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6957 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 9073 | 0.040 |
Why?
|
Empathy | 1 | 2024 | 473 | 0.040 |
Why?
|
Folate Receptor 1 | 1 | 2019 | 40 | 0.040 |
Why?
|
GTP Cyclohydrolase | 1 | 2019 | 47 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 520 | 0.040 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2019 | 108 | 0.040 |
Why?
|
Aggression | 1 | 2023 | 745 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6498 | 0.040 |
Why?
|
Diet Therapy | 1 | 2019 | 151 | 0.040 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2019 | 297 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10827 | 0.040 |
Why?
|
Standard of Care | 1 | 2021 | 552 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2020 | 65017 | 0.030 |
Why?
|
Delphi Technique | 1 | 2020 | 829 | 0.030 |
Why?
|
Prospective Studies | 4 | 2022 | 54303 | 0.030 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1131 | 0.030 |
Why?
|
Housing | 1 | 2021 | 665 | 0.030 |
Why?
|
Opiate Substitution Treatment | 1 | 2019 | 436 | 0.030 |
Why?
|
Age Factors | 2 | 2024 | 18416 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 7021 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 24123 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1511 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8555 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1139 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 935 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42063 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 822 | 0.030 |
Why?
|
Parenting | 1 | 2019 | 695 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1066 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2021 | 1428 | 0.030 |
Why?
|
Peer Group | 1 | 2017 | 674 | 0.020 |
Why?
|
Piperazines | 1 | 2022 | 2525 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2417 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
Executive Function | 1 | 2019 | 1374 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2118 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4899 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 1993 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2362 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2653 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4925 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9280 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8482 | 0.020 |
Why?
|
Hot Flashes | 1 | 2011 | 328 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29749 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36060 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1668 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8056 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4360 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3836 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9631 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 912 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13308 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 6015 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26181 | 0.010 |
Why?
|
Brain | 1 | 2024 | 26951 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41335 | 0.010 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_